Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1992 Mar;75(3):406–413.

Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

M J van Lierop 1, K van Maanen 1, R H Meloen 1, V P Rutten 1, M A de Jong 1, E J Hensen 1
PMCID: PMC1384732  PMID: 1349300

Abstract

We studied proliferative responses of bovine T lymphocytes to foot-and-mouth disease virus (FMDV) serotypes A, O and C as well as to three peptides including the two major B-cell epitopes of FMDV (VP1[141-156] and VP1[200-213]). Peripheral blood mononuclear cells (PBMC) from cattle previously vaccinated with monovalent vaccine responded to both homotypic and heterotypic virus strains. Of 14 FMDV-specific bovine T-cell clones, which were prepared from PBMC of an animal vaccinated with the trivalent vaccine, 11 reacted to each of the three serotypes A, O and C. This indicates that several T-cell epitopes might be conserved among these serotypes. PBMC from one of two cattle immunized with VP1[141-156]KLH, one of two cattle immunized with VP1[200-213]KLH and two of three cattle immunized with CC-VP1[200-213]-PPS-VP1[141-156]-PCG responded to the homotypic virus strain. After immunizations with VP1[200-213]KLH also heterotypic responses were found. Thus, it appears that these two B-cell sites include T-cell determinants that are recognized by some cattle. However, when proliferative responses of PBMC from an animal vaccinated with the trivalent vaccine were tested, no responses were found to VP1[141-156] and VP1[200-213], whereas the response was very poor to CC-VP1[200-213]-PPS-VP1[141-156]-PCG. These results suggest that these sequences do not represent dominant T-cell epitopes and/or that T-cell reactivity towards these synthetic peptides does not completely cover the T-cell reactivity towards the fragments present after processing of the whole virus.

Full text

PDF
406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bahnemann H. G. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch Virol. 1975;47(1):47–56. doi: 10.1007/BF01315592. [DOI] [PubMed] [Google Scholar]
  2. Baldwin C. L., Teale A. J., Naessens J. G., Goddeeris B. M., MacHugh N. D., Morrison W. I. Characterization of a subset of bovine T lymphocytes that express BoT4 by monoclonal antibodies and function: similarity to lymphocytes defined by human T4 and murine L3T4. J Immunol. 1986 Jun 15;136(12):4385–4391. [PubMed] [Google Scholar]
  3. Barnett P. V., Ouldridge E. J., Rowlands D. J., Brown F., Parry N. R. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J Gen Virol. 1989 Jun;70(Pt 6):1483–1491. doi: 10.1099/0022-1317-70-6-1483. [DOI] [PubMed] [Google Scholar]
  4. Baxt B., Morgan D. O., Robertson B. H., Timpone C. A. Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment. J Virol. 1984 Aug;51(2):298–305. doi: 10.1128/jvi.51.2.298-305.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature. 1982 Jul 1;298(5869):30–33. doi: 10.1038/298030a0. [DOI] [PubMed] [Google Scholar]
  6. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  7. Broekhuijsen M. P., Blom T., Kottenhagen M., Pouwels P. H., Meloen R. H., Barteling S. J., Enger-Valk B. E. Synthesis of fusion proteins containing antigenic determinants of foot-and-mouth disease virus. Vaccine. 1986 Jun;4(2):119–124. doi: 10.1016/0264-410x(86)90050-2. [DOI] [PubMed] [Google Scholar]
  8. Clarke B. E., Newton S. E., Carroll A. R., Francis M. J., Appleyard G., Syred A. D., Highfield P. E., Rowlands D. J., Brown F. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. 1987 Nov 26-Dec 2Nature. 330(6146):381–384. doi: 10.1038/330381a0. [DOI] [PubMed] [Google Scholar]
  9. Collen T., Dimarchi R., Doel T. R. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol. 1991 Jan 15;146(2):749–755. [PubMed] [Google Scholar]
  10. Collen T., Doel T. R. Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J Gen Virol. 1990 Feb;71(Pt 2):309–315. doi: 10.1099/0022-1317-71-2-309. [DOI] [PubMed] [Google Scholar]
  11. Cox J. H., Ivanyi J., Young D. B., Lamb J. R., Syred A. D., Francis M. J. Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur J Immunol. 1988 Dec;18(12):2015–2019. doi: 10.1002/eji.1830181222. [DOI] [PubMed] [Google Scholar]
  12. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science. 1986 May 2;232(4750):639–641. doi: 10.1126/science.3008333. [DOI] [PubMed] [Google Scholar]
  13. Doel T. R., Baccarini P. J. Thermal stability of foot-and-mouth disease virus. Arch Virol. 1981;70(1):21–32. doi: 10.1007/BF01320790. [DOI] [PubMed] [Google Scholar]
  14. Doel T. R., Gale C., Brooke G., DiMarchi R. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1. J Gen Virol. 1988 Sep;69(Pt 9):2403–2406. doi: 10.1099/0022-1317-69-9-2403. [DOI] [PubMed] [Google Scholar]
  15. Doel T. R., Gale C., Do Amaral C. M., Mulcahy G., Dimarchi R. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. J Virol. 1990 May;64(5):2260–2264. doi: 10.1128/jvi.64.5.2260-2264.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Doel T. R. Prospects for improved foot and mouth disease vaccines. Vaccine. 1985 Mar;3(1):35–36. doi: 10.1016/0264-410x(85)90008-8. [DOI] [PubMed] [Google Scholar]
  17. Fish R. C., van Bekkum J. G., Lehmann R. P., Richardson G. V. Immunologic responses in Dutch cattle vaccinated with foot-and-mouth disease vaccines under field conditions: neutralizing antibody responses to O, A, and C types. Am J Vet Res. 1969 Dec;30(12):2115–2123. [PubMed] [Google Scholar]
  18. Fournier A., Wang C. T., Felix A. M. Applications of BOP reagent in solid phase synthesis. Advantages of BOP reagent for difficult couplings exemplified by a synthesis of [Ala 15]-GRF(1-29)-NH2. Int J Pept Protein Res. 1988 Jan;31(1):86–97. doi: 10.1111/j.1399-3011.1988.tb00010.x. [DOI] [PubMed] [Google Scholar]
  19. Francis M. J., Fry C. M., Rowlands D. J., Bittle J. L., Houghten R. A., Lerner R. A., Brown F. Immune response to uncoupled peptides of foot-and-mouth disease virus. Immunology. 1987 May;61(1):1–6. [PMC free article] [PubMed] [Google Scholar]
  20. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. Immunological priming with synthetic peptides of foot-and-mouth disease virus. J Gen Virol. 1985 Nov;66(Pt 11):2347–2354. doi: 10.1099/0022-1317-66-11-2347. [DOI] [PubMed] [Google Scholar]
  21. Francis M. J., Hastings G. Z., Syred A. D., McGinn B., Brown F., Rowlands D. J. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature. 1987 Nov 12;330(6144):168–170. doi: 10.1038/330168a0. [DOI] [PubMed] [Google Scholar]
  22. King A. M., Underwood B. O., McCahon D., Newman J. W., Brown F. Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK. Nature. 1981 Oct 8;293(5832):479–480. doi: 10.1038/293479a0. [DOI] [PubMed] [Google Scholar]
  23. Liu F. T., Zinnecker M., Hamaoka T., Katz D. H. New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry. 1979 Feb 20;18(4):690–693. doi: 10.1021/bi00571a022. [DOI] [PubMed] [Google Scholar]
  24. Meloen R. H., Barteling S. J. An epitope located at the C terminus of isolated VP1 of foot-and-mouth disease virus type O induces neutralizing activity but poor protection. J Gen Virol. 1986 Feb;67(Pt 2):289–294. doi: 10.1099/0022-1317-67-2-289. [DOI] [PubMed] [Google Scholar]
  25. Meloen R. H., Barteling S. J. Epitope mapping of the outer structural protein VP1 of three different serotypes of foot-and-mouth disease virus. Virology. 1986 Feb;149(1):55–63. doi: 10.1016/0042-6822(86)90086-3. [DOI] [PubMed] [Google Scholar]
  26. Meloen R. H., Briaire J. A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins. J Gen Virol. 1980 Nov;51(Pt 1):107–116. doi: 10.1099/0022-1317-51-1-107. [DOI] [PubMed] [Google Scholar]
  27. Parry N. R., Barnett P. V., Ouldridge E. J., Rowlands D. J., Brown F. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. J Gen Virol. 1989 Jun;70(Pt 6):1493–1503. doi: 10.1099/0022-1317-70-6-1493. [DOI] [PubMed] [Google Scholar]
  28. Parry N. R., Ouldridge E. J., Barnett P. V., Clarke B. E., Francis M. J., Fox J. D., Rowlands D. J., Brown F. Serological prospects for peptide vaccines against foot-and-mouth disease virus. J Gen Virol. 1989 Nov;70(Pt 11):2919–2930. doi: 10.1099/0022-1317-70-11-2919. [DOI] [PubMed] [Google Scholar]
  29. Pfaff E., Mussgay M., Böhm H. O., Schulz G. E., Schaller H. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J. 1982;1(7):869–874. doi: 10.1002/j.1460-2075.1982.tb01262.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shapira M., Jibson M., Muller G., Arnon R. Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2461–2465. doi: 10.1073/pnas.81.8.2461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Suter M. A modified ELISA technique for anti-hapten antibodies. J Immunol Methods. 1982 Aug 27;53(1):103–108. doi: 10.1016/0022-1759(82)90244-7. [DOI] [PubMed] [Google Scholar]
  32. Thomas A. A., Woortmeijer R. J., Barteling S. J., Meloen R. H. Evidence for more than one important, neutralizing site on foot-and-mouth disease virus. Brief report. Arch Virol. 1988;99(3-4):237–242. doi: 10.1007/BF01311072. [DOI] [PubMed] [Google Scholar]
  33. Thomas A. A., Woortmeijer R. J., Puijk W., Barteling S. J. Antigenic sites on foot-and-mouth disease virus type A10. J Virol. 1988 Aug;62(8):2782–2789. doi: 10.1128/jvi.62.8.2782-2789.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Van Maanen C., Terpstra C. Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. J Immunol Methods. 1989 Nov 13;124(1):111–119. doi: 10.1016/0022-1759(89)90192-0. [DOI] [PubMed] [Google Scholar]
  35. van Bekkum J. G., Fish R. C., Nathans I. Immunologic responses in Dutch cattle vaccinated with foot-and-mouth disease vaccines under field conditions: neutralizing antibody responses and immunity to O, A, and C types. Am J Vet Res. 1969 Dec;30(12):2125–2129. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES